drugset

drugset / Trial / NCT00141245

To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

NCT00141245 ↗

Phase 3 Completed 325 enrolled Pfizer

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To evaluate long-term safety and efficacy of pregabalin in patients with partial seizures.

Timeline

Start: 1998-10
Primary completion: —
Completion: 2005-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pregabalin	Small molecule	—	—

Indications